Helpdesk

Sales contact

Home > BYOD

BYOD

Infographic

Why you should implement a BYOD strategy for your eCOA trial

Improve your clinical trial efficiency and offer more choice to patients by implementing a BYOD strategy for your eCOA trial! Download "Kayentis BYOD solution" infographic

Infographic

3 tips to support successful BYOD decision-making for your eCOA trial

BYOD

Bring Your Own Device (BYOD) and Provisioned Device (PD) methods will generally work for any eCOA study, but there are...

White Paper

ePRO data collection: Decision-making for the adoption of a Bring Your Own Device (BYOD) strategy

BYOD

Electronic devices have been systematically provided to participants to report Patient Reported Outcome (PRO) data in clinical trials and electronic...

Infographic

Clin’form App: The Kayentis BYOD solution

BYOD Patient engagement

Clin’form App is the Kayentis BYOD solution, available for patients and caregivers to facilitate decentralized and hybrid trials, and improve...

Infographic

Kayentis BYOD solution: Ensuring adoption by sites and patients

BYOD

What if a patient breaks or loses their smartphone during the study? What if they fear using the Clin’form App...

Infographic

3 Key Recommendations For A Successful BYOD Study

BYOD

BYOD is a patient-centered method of collecting patients’ data electronically during clinical trials, providing strong value for pharma organizations and...

Infographic

Patients are ready for BYOD – are you?

BYOD

Patients are ready to adopt BYOD: 45% of patients prefer BYOD, 40% have no preference, and 15% prefer provisioned device....

White Paper

BYOD: When, why and how?

BYOD

What are the main characteristics that make BYOD a strong feature for decentralized trials? What are the key factors to...

Subscribe to our newsletter

Rare disease clinical research: it is time to tackle what...

The client’s voice: why they consistently choose Kayentis

Why you should join Kayentis

Rethinking pediatric clinical trials: guidelines from pediatric experts

Overcoming challenges in long-lasting pediatric clinical trials – Insights from...

Tackling the specificities of NASH/MASH clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA